SummaryLeft ventricular outflow tract obstruction (LVOTO) is commonly observed in patients with hypertrophic cardiomyopathy (HCM) or left ventricular hypertrophy (LVH). While some patients develop LVOTO at rest, it can also be provoked by physical exertion, and hence termed latent LVOTO (L-LVOTO). Recent reports demonstrated that L-LVOTO develops not only in LVH patients, but also in patients without LVH (non-LVH). However, the prevalence and clinical prognosis of non-LVH patients with L-LVOTO are not yet elucidated. In this study, we retrospectively investigated the echocardiographic features of patients with malignancy who underwent dobutamine stress echocardiography (DSE) to evaluate preoperative cardiac risk. One hundred ninety-nine patients were found not to have LVH or coronary artery disease. Among them, 106 patients exhibited L-LVOTO after DSE. We next compared the baseline echocardiographic features of L-LVOTO (+) patients with those of L-LVOTO (-) patients, and identified the left ventricular outflow tract (LVOT) ratio (systolic LVOT diameter/diastolic LVOT diameter) as a significant predictor of L-LVOTO. An LVOT ratio ≤ 0.83 was the best cutoff value to detect the presence of L-LVOTO, with a sensitivity of 81.1% and specificity of 80.6%. Overall, L-LVOTO was found to develop in almost half of non-LVH patients with malignancy. In addition, the baseline LVOT ratio was strongly related to the presence of L-LVOTO in non-LVH patients. Therefore, patients with dynamic LVOT narrowing may benefit from DSE to detect the presence of L-LVOTO. (Int Heart J 2012; 53: 230-233) Key words: Latent left ventricular outflow tract obstruction, Dobutamine stress echocardiography L eft ventricular outflow obstruction (LVOTO) occurs in about 25% of patients with hypertrophic cardiomyopathy (HCM). 1,2) LVOTO in HCM causes cardiovascular events such as angina, syncope, and heart failure, and is associated with an adverse clinical prognosis.1,2) While some HCM patients do not develop LVOTO at rest, it can be induced by stressors such as exercise or pharmacological stimulation, and has thus been termed latent LVOTO (L-LVOTO).3) L-LVOTO can be even provoked in patients without HCM or significant left ventricular hypertrophy (non-LVH). 4,5) Although L-LVOTO in non-LVH patients has a potential to induce cardiovascular events, the prevalence, clinical course, and prognosis of L-LVOTO in non-LVH patients still remain elusive. Therefore, such patients have to be followed carefully and their clinical outcome characterized.While one useful modality for detecting L-LVOTO is dobutamine stress echocardiography (DSE), 6) it cannot be performed easily in all hospital settings. Accordingly, there is a need for identification of the basic echocardiographic features that suggest the presence of L-LVOTO in non-LVH patients.In this study, we retrospectively investigated the baseline echocardiographic characteristics of non-LVH patients, andshowed that the dynamics of the left ventricular outflow dimension are strongly related to the presence ...